Sort
53,477 grants matching “addiction”
FACULTY AND RESEARCH DEVELOPMENT CORE
$688,443Linda F Samson · Governors State University · P20 · FY2010 · MD
Electrophysiological and electrochemical studues of addictive drugs
$688,396Eugene A Kiyatkin · National Institute On Drug Abuse · ZIA · FY2012 · DA
Contributions of aberrant synaptic protein monoaminylation to opiate use disorder
$688,381Ian S. Maze · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DA
Clinical Trials Network, Ohio Valley Node U10DA013732
$688,350T John Winhusen · University Of Cincinnati · U10 · FY2013 · DA
Clinical Trials Network New England Consortium Node: Admin Supplement CTN0126
$688,344Gail D'onofrio · Yale University · UG1 · FY2022 · DA
Data Driven Strategies for Substance Misuse Identification in Hospitalized Patients
$688,326Majid Afshar · University Of Wisconsin-Madison · R01 · FY2021 · DA
Next Generation Gene Therapy for Refractory Pain
$688,317William Russell Renthal · Brigham And Women'S Hospital · R01 · FY2024 · NS
Modulation of Neuronal Acetylcholine Receptors
$688,287Lorna W Role · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2006 · NS
Applying a multiple methods approach to examine spatial and temporal variability in a state's illicit drug market
$688,271Robert Heimer · Yale University · R01 · FY2025 · DA
in vivo investigation of KOR as a marker of BPD and suicide related endophenotypes
$688,228Margaret Taylor Davis · Yale University · R01 · FY2025 · MH
Opioid therapy for pain in individuals with metastatic cancer: benefits, harms and stakeholder perspectives
$688,177Jessica S Merlin · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · NR
Modulation of Neuronal Acetylcholine Receptors
$688,169Lorna W Role · State University New York Stony Brook · R01 · FY2009 · NS
The Biological Basis of Alcohol-and Smoking-Induced Brain Injury
$688,094Dieter J Meyerhoff · Northern California Institute/Res/Edu · R01 · FY2007 · AA
Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)
$688,020Jan Gryczynski · Friends Research Institute, Inc. · R01 · FY2023 · DA
Investigating Efficacious E-Cigarette Interventions and Cessation Effects on Cancer-Related Biomarkers: A Randomized Trial of Varenicline in Adults
$687,995Lisa M Fucito · Yale University · R01 · FY2025 · CA
Kinetics of Drug Macromolecule Complex Formation
$687,969Palmer W Taylor · University Of California, San Diego · R01 · FY2013 · GM
Neurocircuitry of Temperament and Motivated Behavior in Adolescent Eating Disorders
$687,968Amanda B Grethe · University Of California, San Diego · R01 · FY2020 · MH
Cannabinergic Medications for Methamphetamine Addiction
$687,900Alexandros Makriyannis · Northeastern University · R37 · FY2013 · DA
Dual Mechanisms of Cognitive Control
$687,830Todd Braver · Washington University · R37 · FY2014 · MH
Development of Natural Product Leads as Anticancer Therapeutics
$687,723John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Optimizing lifestyle interventions with mindfulness-based strategies in type 2 diabetes
$687,721Frederick M Hecht · University Of California, San Francisco · R33 · FY2020 · AT
Intraganglionic Analgesic Adeno-Associated Virus (AAV) Gene Vector Optimization in Large Animals
$687,599Andreas S Beutler · Interventional Analgesix, Inc. · R01 · FY2020 · NS
Effectiveness and Implementation of a Meditation App addressing Substance Use, Sexual Health, and Emotion Regulation among Legal-Involved Youth
$687,540Ashley D. Kendall · University Of Illinois At Chicago · R01 · FY2025 · DA
ENIGMA-SD: Understanding Sex Differences in Global Mental Health through ENIGMA
$687,453Paul M Thompson · University Of Southern California · R01 · FY2018 · MH
Targeted small molecule recruitment to suppress the HIV transcriptionally active reservoir
$687,416Melanie Maria Ott · J. David Gladstone Institutes · R01 · FY2025 · DA